| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 SLCO2B1 ABCB5 ABCC9 GRIN2C SLC18B1 ABCA10 SLC2A3 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 KCNJ5 KCNJ9 ORAI3 TIMM17A LRP5 ATP13A3 SLC5A12 ATP2A3 ATP2B2 DISP1 SLC25A45 | 8.24e-09 | 1180 | 147 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 SLCO2B1 ABCB5 ABCC9 GRIN2C SLC18B1 ABCA10 SLC2A3 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 KCNJ5 KCNJ9 ORAI3 TIMM17A LRP5 ATP13A3 SLC5A12 ATP2A3 ATP2B2 DISP1 SLC25A45 | 5.70e-08 | 1289 | 147 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 KCNJ5 KCNJ9 ORAI3 ATP13A3 SLC5A12 ATP2A3 ATP2B2 | 3.68e-07 | 793 | 147 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 KCNJ5 KCNJ9 ORAI3 SLC5A12 ATP2A3 ATP2B2 | 7.60e-07 | 758 | 147 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 9.46e-07 | 441 | 147 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 ABCC9 GRIN2C RYR1 KCNH4 ITPR1 ORAI1 CLCN6 KCNJ5 KCNJ9 ORAI3 | 1.55e-06 | 459 | 147 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 ITPR1 KCNJ5 KCNJ9 | 1.70e-06 | 193 | 147 | 10 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 ITPR1 KCNJ5 KCNJ9 | 2.05e-06 | 197 | 147 | 10 | GO:0022834 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DNAH14 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 2.90e-06 | 614 | 147 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 KCNH4 ITPR1 CLCN6 KCNJ5 KCNJ9 | 7.02e-06 | 334 | 147 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.28e-06 | 37 | 147 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 ABCC9 GRIN2C RYR1 KCNH4 ITPR1 ORAI1 CLCN6 KCNJ5 KCNJ9 ORAI3 | 7.94e-06 | 525 | 147 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 7.96e-06 | 18 | 147 | 4 | GO:0022851 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRE NOX5 ABCC9 GRIN2C RYR1 KCNH4 ITPR1 ORAI1 CLCN6 KCNJ5 KCNJ9 ORAI3 | 8.12e-06 | 526 | 147 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.00e-05 | 19 | 147 | 4 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.86e-05 | 22 | 147 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | NOX5 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 ATP13A3 SLC5A12 ATP2A3 ATP2B2 | 3.20e-05 | 664 | 147 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ABCC9 GRIN2C RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 SLC5A12 ATP2A3 ATP2B2 | 4.11e-05 | 465 | 147 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | NOX5 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 SLC5A12 ATP2A3 ATP2B2 | 6.20e-05 | 627 | 147 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 6.21e-05 | 57 | 147 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.96e-05 | 60 | 147 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.17e-04 | 65 | 147 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.17e-04 | 65 | 147 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.29e-04 | 151 | 147 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.56e-04 | 109 | 147 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.66e-04 | 70 | 147 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.30e-04 | 75 | 147 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.33e-04 | 343 | 147 | 10 | GO:0005261 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.61e-04 | 77 | 147 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.94e-04 | 18 | 147 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | G-protein activated inward rectifier potassium channel activity | 3.20e-04 | 4 | 147 | 2 | GO:0015467 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 3.20e-04 | 4 | 147 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.06e-04 | 182 | 147 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.33e-04 | 184 | 147 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.36e-04 | 86 | 147 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.62e-04 | 49 | 147 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.99e-04 | 50 | 147 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.00e-04 | 140 | 147 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 6.07e-04 | 775 | 147 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLCO2B1 ABCB5 ABCC9 SLC18B1 ABCA10 SLC9A5 CLCN6 ATP13A3 SLC5A12 ATP2A3 ATP2B2 | 8.26e-04 | 477 | 147 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.68e-04 | 100 | 147 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 9.91e-04 | 103 | 147 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 1.10e-03 | 7 | 147 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 1.12e-03 | 28 | 147 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.12e-03 | 28 | 147 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.13e-03 | 62 | 147 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DIP2B KIF6 STXBP5L BCAS3 CAPN3 APC2 MTSS1 OBSCN ARFGEF2 KIFAP3 ARHGEF10 TTLL4 TLN1 RACGAP1 TLN2 KIF2A UTRN HTT | 1.21e-03 | 1099 | 147 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 1.35e-03 | 839 | 147 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 1.37e-03 | 840 | 147 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF6 PMS2 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DQX1 KIF2A ATP13A3 ATP2A3 ATP2B2 | 1.37e-03 | 840 | 147 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.37e-03 | 30 | 147 | 3 | GO:0016417 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.51e-03 | 31 | 147 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.69e-03 | 171 | 147 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.81e-03 | 118 | 147 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | integrin binding | 1.90e-03 | 175 | 147 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.07e-03 | 178 | 147 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.33e-03 | 125 | 147 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.34e-03 | 36 | 147 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.34e-03 | 36 | 147 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 2.64e-03 | 78 | 147 | 4 | GO:0051536 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.68e-03 | 129 | 147 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 2.83e-03 | 11 | 147 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | mismatch repair complex binding | 2.83e-03 | 11 | 147 | 2 | GO:0032404 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.83e-03 | 11 | 147 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | metal cluster binding | 3.30e-03 | 83 | 147 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 3.38e-03 | 12 | 147 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 3.38e-03 | 12 | 147 | 2 | GO:0031726 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | PCGF2 TRIO STXBP5L BCAS3 CAPN3 SH2D3C OBSCN ARFGEF2 PSMD2 CHM BIRC6 SERPINI1 GPC3 ARHGEF10 CST6 RACGAP1 CCL3 CCL3L1 ATP2A3 PREX1 | 3.78e-03 | 1418 | 147 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | CCR5 chemokine receptor binding | 3.98e-03 | 13 | 147 | 2 | GO:0031730 | |
| GeneOntologyMolecularFunction | vinculin binding | 3.98e-03 | 13 | 147 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | kinase activity | ILK ATR TRIO OBSCN DAPK1 RBKS SEPHS2 MTOR N4BP2 UCKL1 CCL3 CCL3L1 EIF2AK4 | 4.29e-03 | 764 | 147 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | titin binding | 4.62e-03 | 14 | 147 | 2 | GO:0031432 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 5.00e-03 | 47 | 147 | 3 | GO:0051539 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.23e-03 | 151 | 147 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.38e-03 | 152 | 147 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 5.62e-03 | 49 | 147 | 3 | GO:0048487 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ILK ATR TRIO OBSCN DAPK1 RBKS MTOR N4BP2 UCKL1 CCL3 CCL3L1 EIF2AK4 | 6.25e-03 | 709 | 147 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | Wnt receptor activity | 6.81e-03 | 17 | 147 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 6.81e-03 | 17 | 147 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 6.86e-03 | 102 | 147 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.00e-03 | 301 | 147 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | calmodulin binding | 7.20e-03 | 230 | 147 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 7.35e-03 | 231 | 147 | 6 | GO:0005085 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRB2 GABRB3 GABRE MCHR1 NOX5 SLCO2B1 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 MTOR KCNJ5 KCNJ9 RACGAP1 ORAI3 CCL3 ATP13A3 SLC5A12 ATP2A3 UTRN ATP2B2 HTT | 9.61e-08 | 1374 | 146 | 29 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 GABRB2 GABRB3 GABRE NOX5 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 MTOR KCNJ5 KCNJ9 ORAI3 CCL3 ATP2A3 UTRN ATP2B2 HTT | 1.98e-07 | 1017 | 146 | 24 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRB2 GABRB3 GABRE NOX5 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 CLCN6 MTOR KCNJ5 KCNJ9 ORAI3 CCL3 ATP13A3 ATP2A3 UTRN ATP2B2 HTT | 2.79e-07 | 1115 | 146 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | cellular response to histamine | 1.19e-05 | 7 | 146 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | NOX5 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 CCL3 ATP13A3 ATP2A3 UTRN ATP2B2 HTT | 3.79e-05 | 942 | 146 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | GABRE MCHR1 CAPN3 ABCC9 GRIN2C ITPR1 ORAI1 MTOR KCNJ5 KCNJ9 CCL3 UTRN ATP2B2 HTT | 6.27e-05 | 577 | 146 | 14 | GO:0043269 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | MCHR1 NOX5 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 CCL3 ATP13A3 SLC5A12 ATP2A3 UTRN ATP2B2 HTT | 6.64e-05 | 1157 | 146 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | response to histamine | 7.29e-05 | 12 | 146 | 3 | GO:0034776 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | NOX5 CAPN3 ABCC9 GRIN2C SLC18B1 RYR1 KCNH4 ITPR1 ORAI1 SLC9A5 KCNJ5 KCNJ9 ORAI3 CCL3 ATP2A3 UTRN ATP2B2 HTT | 9.32e-05 | 922 | 146 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.06e-04 | 35 | 146 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.10e-04 | 153 | 146 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.15e-04 | 154 | 146 | 7 | GO:0051928 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | GABRB1 GABRB2 GABRB3 GABRE ATR ZDHHC5 ARFGEF2 ITPR1 KIF2A ATP2B2 | 2.70e-07 | 164 | 148 | 10 | GO:0098982 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 8.61e-06 | 19 | 148 | 4 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.31e-05 | 21 | 148 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 KCNH4 ORAI1 KCNJ5 KCNJ9 | 8.19e-05 | 378 | 148 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | postsynapse | GABRB1 GABRB2 GABRB3 GABRE ATR TRIO APC2 ZDHHC5 ARFGEF2 DAPK1 GRIN2C ZDHHC8 ITPR1 KIFAP3 SLC9A5 MTOR UTRN ATP2B2 HTT | 1.07e-04 | 1018 | 148 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | cell leading edge | GABRE ILK BCAS3 APC2 MTSS1 SH2D3C KANK1 SLC9A5 PTPRM TLN1 TLN2 ATP2B2 | 2.37e-04 | 500 | 148 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | chloride channel complex | 7.12e-04 | 57 | 148 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | leading edge membrane | 7.56e-04 | 210 | 148 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRB2 GABRB3 GABRE GRIN2C SLC2A3 ITPR1 SLC9A5 KCNJ9 UTRN ATP2B2 HTT | 9.25e-04 | 583 | 148 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | cell projection membrane | GABRE MCHR1 APC2 SH2D3C KANK1 SLC9A5 TLN1 UTRN ATP2B2 PHLPP2 | 1.02e-03 | 431 | 148 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.02e-03 | 161 | 148 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 KCNH4 ORAI1 KCNJ5 KCNJ9 | 1.27e-03 | 523 | 148 | 11 | GO:1902495 |
| Domain | GABAAb_rcpt | 4.68e-07 | 3 | 146 | 3 | IPR002289 | |
| Domain | - | 9.95e-06 | 222 | 146 | 10 | 1.25.10.10 | |
| Domain | ARM-type_fold | ATR APC2 ARFGEF2 PSMD2 BTAF1 ITPR1 DNAAF5 KIFAP3 MTOR NOM1 AP1G2 HTT | 1.47e-05 | 339 | 146 | 12 | IPR016024 |
| Domain | GABAA/Glycine_rcpt | 2.83e-05 | 23 | 146 | 4 | IPR006028 | |
| Domain | ARM-like | 5.32e-05 | 270 | 146 | 10 | IPR011989 | |
| Domain | - | 6.07e-05 | 2 | 146 | 2 | 1.20.1420.10 | |
| Domain | VBS | 6.07e-05 | 2 | 146 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 6.07e-05 | 2 | 146 | 2 | IPR015009 | |
| Domain | Talin_cent | 6.07e-05 | 2 | 146 | 2 | IPR015224 | |
| Domain | Talin_middle | 6.07e-05 | 2 | 146 | 2 | PF09141 | |
| Domain | HEAT | 8.95e-05 | 58 | 146 | 5 | IPR000357 | |
| Domain | Dynein_HC_stalk | 1.60e-04 | 14 | 146 | 3 | IPR024743 | |
| Domain | MT | 1.60e-04 | 14 | 146 | 3 | PF12777 | |
| Domain | Orai-1 | 1.81e-04 | 3 | 146 | 2 | PF07856 | |
| Domain | CRAC_channel | 1.81e-04 | 3 | 146 | 2 | IPR012446 | |
| Domain | Talin-1 | 1.81e-04 | 3 | 146 | 2 | IPR015710 | |
| Domain | DHC_fam | 1.99e-04 | 15 | 146 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.99e-04 | 15 | 146 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.99e-04 | 15 | 146 | 3 | IPR004273 | |
| Domain | HEAT_REPEAT | 2.19e-04 | 70 | 146 | 5 | PS50077 | |
| Domain | GDS_CDC24_CS | 2.38e-04 | 39 | 146 | 4 | IPR001331 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.94e-04 | 17 | 146 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.94e-04 | 17 | 146 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.50e-04 | 18 | 146 | 3 | PF00690 | |
| Domain | ILWEQ_dom | 3.60e-04 | 4 | 146 | 2 | IPR002558 | |
| Domain | ILWEQ | 3.60e-04 | 4 | 146 | 2 | SM00307 | |
| Domain | FERM_f0 | 3.60e-04 | 4 | 146 | 2 | PF16511 | |
| Domain | ILWEQ | 3.60e-04 | 4 | 146 | 2 | PD011820 | |
| Domain | - | 3.60e-04 | 4 | 146 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 3.60e-04 | 4 | 146 | 2 | PF01608 | |
| Domain | I_LWEQ | 3.60e-04 | 4 | 146 | 2 | PS50945 | |
| Domain | FERM_f0 | 3.60e-04 | 4 | 146 | 2 | IPR032425 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.14e-04 | 19 | 146 | 3 | IPR004014 | |
| Domain | Neurotransmitter_ion_chnl_CS | 4.16e-04 | 45 | 146 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 4.53e-04 | 46 | 146 | 4 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 4.92e-04 | 47 | 146 | 4 | IPR006029 | |
| Domain | - | 4.92e-04 | 47 | 146 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.92e-04 | 47 | 146 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.92e-04 | 47 | 146 | 4 | PS00236 | |
| Domain | Neur_channel | 4.92e-04 | 47 | 146 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.92e-04 | 47 | 146 | 4 | IPR006202 | |
| Domain | HEAT | 5.34e-04 | 48 | 146 | 4 | PF02985 | |
| Domain | FATC | 5.98e-04 | 5 | 146 | 2 | PF02260 | |
| Domain | DUF4371 | 5.98e-04 | 5 | 146 | 2 | IPR025398 | |
| Domain | DUF4371 | 5.98e-04 | 5 | 146 | 2 | PF14291 | |
| Domain | RIH_assoc-dom | 8.92e-04 | 6 | 146 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.92e-04 | 6 | 146 | 2 | PF08709 | |
| Domain | RIH_assoc | 8.92e-04 | 6 | 146 | 2 | PF08454 | |
| Domain | RIH_dom | 8.92e-04 | 6 | 146 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.92e-04 | 6 | 146 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.92e-04 | 6 | 146 | 2 | IPR015925 | |
| Domain | FAT | 8.92e-04 | 6 | 146 | 2 | PS51189 | |
| Domain | FATC | 8.92e-04 | 6 | 146 | 2 | PS51190 | |
| Domain | - | 8.92e-04 | 6 | 146 | 2 | 1.25.10.30 | |
| Domain | FAT | 8.92e-04 | 6 | 146 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 8.92e-04 | 6 | 146 | 2 | IPR003151 | |
| Domain | FATC_dom | 8.92e-04 | 6 | 146 | 2 | IPR003152 | |
| Domain | RYDR_ITPR | 8.92e-04 | 6 | 146 | 2 | PF01365 | |
| Domain | PIK_FAT | 8.92e-04 | 6 | 146 | 2 | IPR014009 | |
| Domain | FATC | 8.92e-04 | 6 | 146 | 2 | SM01343 | |
| Domain | EF-hand_5 | 9.49e-04 | 25 | 146 | 3 | PF13202 | |
| Domain | P-loop_NTPase | DNHD1 KIF6 ERCC2 VPS4A ABCB5 DHX38 DNAH2 DAPK1 ABCC9 BTAF1 ABCA10 DNAH14 DQX1 N4BP2 UCKL1 KIF2A | 9.88e-04 | 848 | 146 | 16 | IPR027417 |
| Domain | Vinculin/catenin | 1.24e-03 | 7 | 146 | 2 | IPR006077 | |
| Domain | Znf_MYM | 1.24e-03 | 7 | 146 | 2 | IPR010507 | |
| Domain | zf-FCS | 1.24e-03 | 7 | 146 | 2 | PF06467 | |
| Domain | DH_1 | 1.49e-03 | 63 | 146 | 4 | PS00741 | |
| Domain | TRASH_dom | 1.65e-03 | 8 | 146 | 2 | IPR011017 | |
| Domain | TRASH | 1.65e-03 | 8 | 146 | 2 | SM00746 | |
| Domain | - | 1.97e-03 | 32 | 146 | 3 | 3.40.1110.10 | |
| Domain | - | 1.97e-03 | 32 | 146 | 3 | 2.70.150.10 | |
| Domain | RhoGEF | 1.98e-03 | 68 | 146 | 4 | SM00325 | |
| Domain | Isoprenoid_synthase_dom | 2.11e-03 | 9 | 146 | 2 | IPR008949 | |
| Domain | RhoGEF | 2.20e-03 | 70 | 146 | 4 | PF00621 | |
| Domain | DH_2 | 2.20e-03 | 70 | 146 | 4 | PS50010 | |
| Domain | - | 2.32e-03 | 71 | 146 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.32e-03 | 71 | 146 | 4 | IPR000219 | |
| Domain | EF-hand_8 | 2.34e-03 | 34 | 146 | 3 | PF13833 | |
| Domain | ATPase_P-typ_cyto_domN | 2.55e-03 | 35 | 146 | 3 | IPR023299 | |
| Domain | MIR | 2.62e-03 | 10 | 146 | 2 | PF02815 | |
| Domain | MIR_motif | 2.62e-03 | 10 | 146 | 2 | IPR016093 | |
| Domain | MIR | 2.62e-03 | 10 | 146 | 2 | PS50919 | |
| Domain | MIR | 2.62e-03 | 10 | 146 | 2 | SM00472 | |
| Domain | Hydrolase_3 | 2.62e-03 | 10 | 146 | 2 | PF08282 | |
| Domain | ATPase_P-typ_P_site | 2.77e-03 | 36 | 146 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.77e-03 | 36 | 146 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.77e-03 | 36 | 146 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.99e-03 | 37 | 146 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.99e-03 | 37 | 146 | 3 | PF00122 | |
| Domain | ABC_transporter_CS | 4.30e-03 | 42 | 146 | 3 | IPR017871 | |
| Domain | - | 4.49e-03 | 261 | 146 | 7 | 1.10.238.10 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-03 | 14 | 146 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-03 | 14 | 146 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-03 | 14 | 146 | 2 | PF08393 | |
| Domain | IRS | 5.19e-03 | 14 | 146 | 2 | PF02174 | |
| Domain | IRS_PTB | 5.19e-03 | 14 | 146 | 2 | IPR002404 | |
| Domain | AAA_8 | 5.19e-03 | 14 | 146 | 2 | PF12780 | |
| Domain | AAA | 5.50e-03 | 144 | 146 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 5.50e-03 | 144 | 146 | 5 | IPR003593 | |
| Domain | - | DNHD1 ERCC2 VPS4A ABCB5 DHX38 DNAH2 ABCC9 BTAF1 ABCA10 DNAH14 DQX1 N4BP2 UCKL1 | 5.75e-03 | 746 | 146 | 13 | 3.40.50.300 |
| Domain | PI3/4_kinase_CS | 5.96e-03 | 15 | 146 | 2 | IPR018936 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 9.42e-06 | 54 | 129 | 6 | M27460 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 1.33e-05 | 119 | 129 | 8 | M48309 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.16e-04 | 28 | 129 | 4 | M924 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.31e-04 | 54 | 129 | 5 | MM15202 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.74e-04 | 31 | 129 | 4 | M39369 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.17e-04 | 60 | 129 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.17e-04 | 60 | 129 | 5 | M976 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DGCR2 ERCC2 TRIO BCAS3 OBSCN ZDHHC5 PSMB10 ARFGEF2 BTAF1 BIRC6 ZDHHC8 RYR1 ORAI1 SEPHS2 MTOR UCKL1 TTLL4 TLN1 MCM3AP LRP5 AP1G2 TLN2 SYVN1 ATP2A3 PREX1 HTT | 1.58e-12 | 1105 | 149 | 26 | 35748872 |
| Pubmed | 1.61e-09 | 5 | 149 | 4 | 15198677 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 4.82e-09 | 6 | 149 | 4 | 10023064 | |
| Pubmed | VWF ILK TRIO PEG10 CAPN3 OBSCN BIRC6 RYR1 AKAP12 GPC3 FDFT1 TLN1 KDM2A UTRN | 3.46e-08 | 497 | 149 | 14 | 23414517 | |
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 7.71e-08 | 3 | 149 | 3 | 7893750 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 1282920 | ||
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 7.71e-08 | 3 | 149 | 3 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 7.71e-08 | 3 | 149 | 3 | 15337300 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LIAS EDC3 OR52L1 OBSCN DNAH2 BIRC6 DNAH14 RYR1 DQX1 KCNJ9 TLN1 MCM3AP BOD1L1 UTRN ZNF304 | 7.06e-07 | 736 | 149 | 15 | 29676528 |
| Pubmed | An additive effect of protective host genetic factors correlates with HIV nonprogression status. | 7.66e-07 | 5 | 149 | 3 | 21084992 | |
| Pubmed | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. | 7.66e-07 | 5 | 149 | 3 | 9039914 | |
| Pubmed | 9.45e-07 | 18 | 149 | 4 | 19078961 | ||
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 1.53e-06 | 6 | 149 | 3 | 29706582 | |
| Pubmed | A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. | 2.23e-06 | 22 | 149 | 4 | 12417987 | |
| Pubmed | ERCC2 HLA-C VPS4A CAPNS1 RO60 TSNAX DNAAF5 WDR11 MTOR NOM1 TIMM17A POLR1B KIF2A | 2.31e-06 | 606 | 149 | 13 | 36538041 | |
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 2.66e-06 | 7 | 149 | 3 | 20843900 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 28676743 | ||
| Pubmed | 3.28e-06 | 53 | 149 | 5 | 36265442 | ||
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 11528422 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SEH1L ILK PEG10 PSMA6 DHX38 CAPNS1 CARS1 ARFGEF2 PSMD2 RO60 TSNAX BIRC6 LAP3 YARS1 AKAP12 DNAAF5 ARHGEF10 MTOR TLN1 HTT | 4.36e-06 | 1455 | 149 | 20 | 22863883 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 6.00e-06 | 104 | 149 | 6 | 31240132 | |
| Pubmed | 6.17e-06 | 225 | 149 | 8 | 12168954 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 17502376 | ||
| Pubmed | DIP2B EDC3 ILK HLA-C DHX38 ZDHHC5 ARFGEF2 PSMD2 TYSND1 BIRC6 ITPR1 ORAI1 WDR11 MTOR KIF2A ATP13A3 SYVN1 | 1.16e-05 | 1168 | 149 | 17 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 ATR HLA-C TRIO VPS4A PSMA6 DHX38 CARS1 PSMD2 RO60 LAP3 YARS1 MTOR TLN1 RACGAP1 DLAT TLN2 BOD1L1 KIF2A | 1.18e-05 | 1425 | 149 | 19 | 30948266 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | SEH1L ILK ATR HLA-C VPS4A CAPNS1 RO60 DNAAF5 WDR11 FDFT1 TIMM17A DLAT POLR1B KIF2A UTRN | 1.21e-05 | 931 | 149 | 15 | 27432908 |
| Pubmed | Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. | 1.24e-05 | 11 | 149 | 3 | 32093570 | |
| Pubmed | Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. | 1.82e-05 | 2 | 149 | 2 | 19887627 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26950270 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 23486367 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26445441 | ||
| Pubmed | Communication between N terminus and loop2 tunes Orai activation. | 1.82e-05 | 2 | 149 | 2 | 29237733 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12196556 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12654335 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15457513 | ||
| Pubmed | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway. | 1.82e-05 | 2 | 149 | 2 | 27930338 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25241062 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 23216249 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25049274 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17141218 | ||
| Pubmed | Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. | 1.82e-05 | 2 | 149 | 2 | 13679430 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 14503638 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22399227 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27410476 | ||
| Pubmed | Direct binding of GABAA receptor β2 and β3 subunits to gephyrin. | 1.82e-05 | 2 | 149 | 2 | 23205938 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18420579 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 20395295 | ||
| Pubmed | Force-Dependent Regulation of Talin-KANK1 Complex at Focal Adhesions. | 1.82e-05 | 2 | 149 | 2 | 31389241 | |
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 1.82e-05 | 2 | 149 | 2 | 21735059 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 1.82e-05 | 2 | 149 | 2 | 26523364 | |
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 1.82e-05 | 2 | 149 | 2 | 18650446 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18239147 | ||
| Pubmed | Discordant regulation of eIF2 kinase GCN2 and mTORC1 during nutrient stress. | 1.82e-05 | 2 | 149 | 2 | 34023907 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31327495 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22989919 | ||
| Pubmed | Increased glutamine catabolism mediates bone anabolism in response to WNT signaling. | 1.82e-05 | 2 | 149 | 2 | 25562323 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11997063 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17991693 | ||
| Pubmed | Are Orai1 and Orai3 channels more important than calcium influx for cell proliferation? | 1.82e-05 | 2 | 149 | 2 | 24321771 | |
| Pubmed | Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. | 1.82e-05 | 2 | 149 | 2 | 20354224 | |
| Pubmed | SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. | 1.82e-05 | 2 | 149 | 2 | 30554864 | |
| Pubmed | Facilitation of Orai3 targeting and store-operated function by Orai1. | 1.82e-05 | 2 | 149 | 2 | 25791427 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22306379 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 20656890 | ||
| Pubmed | Interaction of Huntington disease protein with transcriptional activator Sp1. | 1.82e-05 | 2 | 149 | 2 | 11839795 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27430888 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 21113813 | ||
| Pubmed | Association of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos. | 1.82e-05 | 2 | 149 | 2 | 25250329 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 39135143 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 19055602 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 33760196 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SEH1L ILK VPS4A PSMA6 DHX38 PSMD2 BIRC6 USP16 WDR11 TLN1 MCM3AP RACGAP1 DLAT AP1G2 POLR1B KDM2A KIF2A UTRN | 2.11e-05 | 1353 | 149 | 18 | 29467282 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.13e-05 | 38 | 149 | 4 | 30786075 | |
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 2.13e-05 | 38 | 149 | 4 | 23537643 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE DIP2B TRIO STXBP5L BCAS3 OBSCN BTAF1 TSNAX INTS3 DNAH14 DNAAF5 WDR11 UCKL1 LRP5 KDM2A BOD1L1 EIF2AK4 UTRN HTT | 2.17e-05 | 1489 | 149 | 19 | 28611215 |
| Pubmed | 2.66e-05 | 81 | 149 | 5 | 22723691 | ||
| Pubmed | 2.71e-05 | 14 | 149 | 3 | 22768092 | ||
| Pubmed | 2.71e-05 | 14 | 149 | 3 | 19652092 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SEH1L EDC3 VPS4A PSMA6 DHX38 PSMD2 TSNAX TYSND1 USP16 ARHGEF10 POLR1B EIF2AK4 UTRN ZMYM6 PHLPP2 | 2.94e-05 | 1005 | 149 | 15 | 19615732 |
| Pubmed | 3.38e-05 | 15 | 149 | 3 | 19793892 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DIP2B HLA-C SLCO2B1 ZDHHC5 ARFGEF2 DAPK1 ZDHHC8 SLC2A3 PTPRM MTOR ATP13A3 | 3.69e-05 | 569 | 149 | 11 | 30639242 |
| Pubmed | PMS2 PCGF2 VWF MCHR1 TRIO PEG10 APC2 ARFGEF2 PSMD2 USP16 YARS1 STAB1 ARHGEF10 DLAT TLN2 UTRN PREX1 | 3.89e-05 | 1285 | 149 | 17 | 35914814 | |
| Pubmed | GABRB3 VWF TRIO BCAS3 PSMA6 ARFGEF2 DAPK1 PSMD2 SLC2A3 YARS1 CERS5 CLCN6 TLN1 DLAT TLN2 KIF2A UTRN ATP2B2 | 4.37e-05 | 1431 | 149 | 18 | 37142655 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SEH1L ILK ATR ARFGEF2 PSMD2 BTAF1 INTS3 STAB1 TLN1 RACGAP1 TLN2 | 4.52e-05 | 582 | 149 | 11 | 20467437 |
| Pubmed | 5.37e-05 | 153 | 149 | 6 | 10718198 | ||
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 5.45e-05 | 3 | 149 | 2 | 12422220 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 25578782 | ||
| Pubmed | Transgenic overexpression of furin increases epileptic susceptibility. | 5.45e-05 | 3 | 149 | 2 | 30333479 | |
| Pubmed | Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. | 5.45e-05 | 3 | 149 | 2 | 24954132 | |
| Pubmed | Murine ORAI2 splice variants form functional Ca2+ release-activated Ca2+ (CRAC) channels. | 5.45e-05 | 3 | 149 | 2 | 17463004 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 21636851 | ||
| Pubmed | N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. | 5.45e-05 | 3 | 149 | 2 | 23917429 | |
| Pubmed | Authentic CRAC channel activity requires STIM1 and the conserved portion of the Orai N terminus. | 5.45e-05 | 3 | 149 | 2 | 29237734 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 25759478 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 27841305 | ||
| Pubmed | CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. | 5.45e-05 | 3 | 149 | 2 | 17442569 | |
| Pubmed | Sp1 and KLF15 regulate basal transcription of the human LRP5 gene. | 5.45e-05 | 3 | 149 | 2 | 20141633 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 17452328 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 12499858 | ||
| Interaction | TOP3B interactions | DGCR2 ERCC2 TRIO BCAS3 OBSCN ZDHHC5 PSMB10 ARFGEF2 BTAF1 TSNAX BIRC6 ZDHHC8 YARS1 RYR1 ORAI1 SEPHS2 MTOR UCKL1 TTLL4 TLN1 MCM3AP RACGAP1 DLAT LRP5 AP1G2 TLN2 SYVN1 ATP2A3 PREX1 HTT | 1.38e-07 | 1470 | 144 | 30 | int:TOP3B |
| Interaction | ARFGEF2 interactions | 6.09e-06 | 136 | 144 | 8 | int:ARFGEF2 | |
| Interaction | GPR45 interactions | ATR BTAF1 INTS3 DNAAF5 MTOR FDFT1 NOM1 MCM3AP ATP13A3 ATP2A3 ATP2B2 | 1.07e-05 | 300 | 144 | 11 | int:GPR45 |
| Interaction | PSMD1 interactions | SEH1L VPS4A PSMA6 CAPN3 CARS1 PSMD2 RO60 PTPRM TEX101 RACGAP1 BOD1L1 SYVN1 HTT | 1.77e-05 | 442 | 144 | 13 | int:PSMD1 |
| Interaction | GPR182 interactions | ATR HLA-C ARFGEF2 BTAF1 CERS5 DNAAF5 MTOR FDFT1 NOM1 ATP13A3 ATP2A3 ATP2B2 HTT | 2.40e-05 | 455 | 144 | 13 | int:GPR182 |
| Interaction | MFSD4A interactions | 3.54e-05 | 225 | 144 | 9 | int:MFSD4A | |
| Interaction | GPR17 interactions | ATR ARFGEF2 BTAF1 INTS3 DNAAF5 MTOR FDFT1 ATP13A3 ATP2A3 HTT | 3.74e-05 | 283 | 144 | 10 | int:GPR17 |
| Cytoband | 11p15.4 | 5.19e-05 | 200 | 149 | 6 | 11p15.4 | |
| Cytoband | 12q13.12 | 2.60e-04 | 38 | 149 | 3 | 12q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.43e-04 | 183 | 149 | 5 | chr16q22 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.20e-06 | 19 | 118 | 4 | 563 | |
| GeneFamily | ORAI calcium release-activated calcium modulators | 1.26e-04 | 3 | 118 | 2 | 668 | |
| GeneFamily | Zinc fingers MYM-type | 6.23e-04 | 6 | 118 | 2 | 86 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.10e-04 | 66 | 118 | 4 | 722 | |
| GeneFamily | ATPases Ca2+ transporting | 1.48e-03 | 9 | 118 | 2 | 1209 | |
| GeneFamily | Proteasome | 2.77e-03 | 43 | 118 | 3 | 690 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K0 | 1.99e-05 | 122 | 144 | 7 | facebase_RNAseq_e10.5_MaxArch_2500_K0 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MTSS1 RBKS SLC2A3 STAB1 KANK1 FCER2 CST6 CCL3 CCL3L1 ATP13A3 | 1.02e-09 | 193 | 148 | 10 | 837c61408462c519912ecf3b83fdc72cd85fe88f |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MTSS1 RBKS SLC2A3 STAB1 KANK1 FCER2 CST6 CCL3 CCL3L1 ATP13A3 | 1.02e-09 | 193 | 148 | 10 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class （2021.01.30） | 1.79e-08 | 193 | 148 | 9 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.79e-08 | 193 | 148 | 9 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-08 | 193 | 148 | 9 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.87e-08 | 194 | 148 | 9 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.87e-08 | 194 | 148 | 9 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 1.87e-08 | 194 | 148 | 9 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.87e-08 | 194 | 148 | 9 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 3.14e-07 | 196 | 148 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 181 | 148 | 7 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 191 | 148 | 7 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-06 | 193 | 148 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.85e-06 | 193 | 148 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 3.85e-06 | 193 | 148 | 7 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-06 | 195 | 148 | 7 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 196 | 148 | 7 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-06 | 199 | 148 | 7 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.86e-06 | 200 | 148 | 7 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 159 | 148 | 6 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 159 | 148 | 6 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 1.84e-05 | 164 | 148 | 6 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 1.84e-05 | 164 | 148 | 6 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 165 | 148 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-05 | 172 | 148 | 6 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 173 | 148 | 6 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 173 | 148 | 6 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.74e-05 | 176 | 148 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.92e-05 | 178 | 148 | 6 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 182 | 148 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 182 | 148 | 6 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 182 | 148 | 6 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 182 | 148 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 183 | 148 | 6 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.84e-05 | 187 | 148 | 6 | bde6b90955423eab6a91a0abe75d0a95a1f5330a | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.84e-05 | 187 | 148 | 6 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.84e-05 | 187 | 148 | 6 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 148 | 6 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | Control-Myeloid-MoAM1|Control / Disease group,lineage and cell class （2021.01.30） | 4.08e-05 | 189 | 148 | 6 | 55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.08e-05 | 189 | 148 | 6 | ebb5e069fdca7cf8ffac16a57572e92d2593c86a | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.08e-05 | 189 | 148 | 6 | a59e4eaff430a443f9fa7edabe64e66a15b6bffb | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.20e-05 | 190 | 148 | 6 | 5c8aa310886c64ee5dce4ba46a3dd178da549529 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.20e-05 | 190 | 148 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.20e-05 | 190 | 148 | 6 | 4b4fe93061c87605dddf5bec94fa07c749c722aa | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 190 | 148 | 6 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 191 | 148 | 6 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 191 | 148 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.32e-05 | 191 | 148 | 6 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 192 | 148 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.58e-05 | 193 | 148 | 6 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-05 | 193 | 148 | 6 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 193 | 148 | 6 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.58e-05 | 193 | 148 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.72e-05 | 194 | 148 | 6 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 4.72e-05 | 194 | 148 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.72e-05 | 194 | 148 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.72e-05 | 194 | 148 | 6 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 195 | 148 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.85e-05 | 195 | 148 | 6 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.85e-05 | 195 | 148 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.85e-05 | 195 | 148 | 6 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 195 | 148 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 4.85e-05 | 195 | 148 | 6 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.99e-05 | 196 | 148 | 6 | d9b5eaca4089d5337f1175a663418c9c675cdd87 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-05 | 197 | 148 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-05 | 197 | 148 | 6 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | COVID-19_Severe-PLT_2|World / Disease Group and Platelet Clusters | 5.14e-05 | 197 | 148 | 6 | b6267c624c2e0070c34bba54bf5362466a2dbf34 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 5.14e-05 | 197 | 148 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.28e-05 | 198 | 148 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.28e-05 | 198 | 148 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.28e-05 | 198 | 148 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.28e-05 | 198 | 148 | 6 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 198 | 148 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.28e-05 | 198 | 148 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.28e-05 | 198 | 148 | 6 | ecd93e28bae4152467f6d6621cffc73c301c9795 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.43e-05 | 199 | 148 | 6 | 9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-05 | 199 | 148 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-05 | 200 | 148 | 6 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.58e-05 | 200 | 148 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-05 | 200 | 148 | 6 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| Drug | nimodipine | GABRB2 TPO ABCB5 GRIN2C RYR1 ITPR1 ORAI1 ORAI3 ATP2A3 ATP2B2 | 4.12e-08 | 145 | 149 | 10 | CID000004497 |
| Drug | Etomidate | 5.61e-07 | 11 | 149 | 4 | ctd:D005045 | |
| Drug | sodium | GABRB1 GABRB2 GABRB3 GABRE LIAS MCHR1 NOX5 SLCO2B1 PEG10 LAP3 SLC2A3 RYR1 SLC9A5 FCER2 PTPRM MTOR KCNJ5 KCNJ9 SLC5A12 ATP2A3 ATP2B2 | 9.45e-07 | 944 | 149 | 21 | CID000000923 |
| Drug | gabapentin | 1.77e-06 | 169 | 149 | 9 | CID000003446 | |
| Drug | pregnanolone | 2.12e-06 | 90 | 149 | 7 | CID000031402 | |
| Drug | CGS 8216 | 2.30e-06 | 33 | 149 | 5 | CID000104916 | |
| Drug | lanthanum | 3.23e-06 | 136 | 149 | 8 | CID000023926 | |
| Drug | dihydroxyaflavinine | 3.92e-06 | 17 | 149 | 4 | CID000156857 | |
| Drug | mag-fura-2 | 4.13e-06 | 37 | 149 | 5 | CID000123839 | |
| Drug | baclofen | 4.84e-06 | 191 | 149 | 9 | CID000002284 | |
| Drug | zaleplon | 5.40e-06 | 39 | 149 | 5 | CID000005719 | |
| Drug | N-methyl-DL-aspartic acid | GABRB1 GABRB2 GABRB3 GABRE TRIO CAPNS1 RHBDL1 DAPK1 GRIN2C RYR1 ITPR1 ORAI1 FCER2 MTOR ORAI3 HTT | 6.49e-06 | 655 | 149 | 16 | CID000004376 |
| Drug | halothane | GABRB1 GABRB2 GABRB3 GABRE RYR1 CYP2W1 ITPR1 ORAI1 ORAI3 ATP2A3 ATP2B2 | 7.35e-06 | 314 | 149 | 11 | CID000003562 |
| Drug | thymol | 1.24e-05 | 46 | 149 | 5 | CID000006989 | |
| Drug | Metformin | SP1 SLCO2B1 CARS1 ARFGEF2 ABCC9 RO60 YARS1 CERS5 SEPHS2 ARHGEF10 MTOR ORAI3 | 1.34e-05 | 400 | 149 | 12 | ctd:D008687 |
| Drug | KB-R7943 | 1.38e-05 | 47 | 149 | 5 | CID004534086 | |
| Drug | Adinazolam | 1.50e-05 | 8 | 149 | 3 | DB00546 | |
| Drug | Fludiazepam | 1.50e-05 | 8 | 149 | 3 | DB01567 | |
| Drug | Clotiazepam | 1.50e-05 | 8 | 149 | 3 | DB01559 | |
| Drug | Cinolazepam | 1.50e-05 | 8 | 149 | 3 | DB01594 | |
| Drug | Prazepam | 1.50e-05 | 8 | 149 | 3 | DB01588 | |
| Drug | Estazolam | 1.50e-05 | 8 | 149 | 3 | DB01215 | |
| Drug | Halazepam | 1.50e-05 | 8 | 149 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.50e-05 | 8 | 149 | 3 | ctd:C091518 | |
| Drug | isoflurane | GABRB1 GABRB2 GABRB3 GABRE ABCC9 GRIN2C RYR1 GPC3 ATP2A3 ATP2B2 | 1.59e-05 | 279 | 149 | 10 | CID000003763 |
| Drug | methohexital | 1.69e-05 | 24 | 149 | 4 | CID000009034 | |
| Drug | bepridil | 1.97e-05 | 126 | 149 | 7 | CID000002351 | |
| Drug | 2-aminoethyl diphenylborinate | 2.07e-05 | 127 | 149 | 7 | CID000001598 | |
| Drug | verapamil | VWF ABCB5 ABCC9 BIRC6 ABCA10 RYR1 ITPR1 ORAI1 KCNJ5 KCNJ9 ORAI3 ATP2A3 ATP2B2 | 2.12e-05 | 490 | 149 | 13 | CID000002520 |
| Drug | Ethchlorvynol | 2.24e-05 | 9 | 149 | 3 | DB00189 | |
| Drug | Diazepam | 2.24e-05 | 9 | 149 | 3 | DB00829 | |
| Drug | xenon | 2.47e-05 | 88 | 149 | 6 | CID000023991 | |
| Drug | triazolam | 2.74e-05 | 54 | 149 | 5 | CID000005556 | |
| Drug | Chlordiazepoxide | 3.19e-05 | 10 | 149 | 3 | DB00475 | |
| Drug | Clobazam | 3.19e-05 | 10 | 149 | 3 | DB00349 | |
| Drug | Bromazepam | 3.19e-05 | 10 | 149 | 3 | DB01558 | |
| Drug | lakh | 3.19e-05 | 10 | 149 | 3 | CID005355255 | |
| Drug | Oxazepam | 3.19e-05 | 10 | 149 | 3 | DB00842 | |
| Drug | Midazolam | 3.19e-05 | 10 | 149 | 3 | DB00683 | |
| Drug | Flurazepam | 3.19e-05 | 10 | 149 | 3 | DB00690 | |
| Drug | Clonazepam | 3.19e-05 | 10 | 149 | 3 | DB01068 | |
| Drug | cytosine | TPO SP1 PMS2 NTHL1 PSMA6 APC2 DAPK1 ABCC9 SERPINI1 UCKL1 UPP2 HTT | 3.49e-05 | 441 | 149 | 12 | CID000000597 |
| Drug | Bicuculline | 3.68e-05 | 29 | 149 | 4 | ctd:D001640 | |
| Drug | NSC759576 | 3.85e-05 | 191 | 149 | 8 | CID000003075 | |
| Drug | flunitrazepam | 4.23e-05 | 59 | 149 | 5 | CID000003380 | |
| Drug | 3-isothujone | 4.23e-05 | 30 | 149 | 4 | CID000011027 | |
| Drug | phaclofen | 4.25e-05 | 2 | 149 | 2 | ctd:C052329 | |
| Drug | Alprazolam | 4.36e-05 | 11 | 149 | 3 | DB00404 | |
| Drug | Temazepam | 4.36e-05 | 11 | 149 | 3 | DB00231 | |
| Drug | Nitrazepam | 4.36e-05 | 11 | 149 | 3 | DB01595 | |
| Drug | Lorazepam | 4.36e-05 | 11 | 149 | 3 | DB00186 | |
| Drug | Leu-Dox | 4.36e-05 | 11 | 149 | 3 | CID000068897 | |
| Drug | Triazolam | 4.36e-05 | 11 | 149 | 3 | DB00897 | |
| Drug | Clorazepate | 4.36e-05 | 11 | 149 | 3 | DB00628 | |
| Drug | R 478 | 4.36e-05 | 11 | 149 | 3 | CID000084223 | |
| Drug | 1 sulfonylurea | 4.44e-05 | 143 | 149 | 7 | CID011819083 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 3837_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 2296_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A | 4.79e-05 | 197 | 149 | 8 | 1718_UP | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 1282_UP | |
| Drug | Dantrolene-13C3 | 4.85e-05 | 145 | 149 | 7 | CID000002951 | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 5314_DN | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 2486_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 1482_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 6073_UP | |
| Drug | C070379 | 5.14e-05 | 199 | 149 | 8 | CID003034747 | |
| Drug | AM 251 | 5.70e-05 | 102 | 149 | 6 | ctd:C103505 | |
| Drug | bupranolol | 5.81e-05 | 63 | 149 | 5 | CID000002475 | |
| Drug | cyclothiazide | 6.02e-05 | 103 | 149 | 6 | CID000002910 | |
| Drug | AC1L2FYN | 6.22e-05 | 33 | 149 | 4 | CID000071333 | |
| Drug | AC1L1J7N | 6.27e-05 | 64 | 149 | 5 | CID000004902 | |
| Drug | loperamide | 6.71e-05 | 105 | 149 | 6 | CID000003954 | |
| Drug | sevoflurane | 6.71e-05 | 105 | 149 | 6 | CID000005206 | |
| Drug | picrotoxinine | 6.76e-05 | 65 | 149 | 5 | CID000004816 | |
| Drug | lindane | 7.10e-05 | 154 | 149 | 7 | CID000000727 | |
| Drug | hepta-3 | 7.49e-05 | 13 | 149 | 3 | CID000150893 | |
| Drug | NSC299933 | 7.49e-05 | 13 | 149 | 3 | CID000431902 | |
| Drug | gallopamil | 7.82e-05 | 67 | 149 | 5 | CID000001234 | |
| Drug | flurazepam | 7.88e-05 | 35 | 149 | 4 | CID000003393 | |
| Drug | enflurane | 8.39e-05 | 68 | 149 | 5 | CID000003226 | |
| Drug | nifedipine | VWF ABCB5 GRIN2C BIRC6 RYR1 CYP2W1 ITPR1 ORAI1 ORAI3 ATP2A3 ATP2B2 | 9.40e-05 | 415 | 149 | 11 | CID000004485 |
| Drug | methyl 9-octadecenoate | 9.60e-05 | 112 | 149 | 6 | CID000008202 | |
| Drug | felbamate | 9.64e-05 | 70 | 149 | 5 | CID000003331 | |
| Drug | secobarbital | 9.83e-05 | 37 | 149 | 4 | CID000005193 | |
| Drug | 4-chloro-m-cresol | 9.83e-05 | 37 | 149 | 4 | CID000001732 | |
| Drug | DMCM | 1.09e-04 | 38 | 149 | 4 | CID000104999 | |
| Drug | hydroxybutyrate | 1.11e-04 | 115 | 149 | 6 | CID000010413 | |
| Drug | acamprosate | 1.26e-04 | 74 | 149 | 5 | CID000071158 | |
| Drug | 3-fluoroisonicotinic acid | 1.27e-04 | 3 | 149 | 2 | CID000345361 | |
| Drug | AC1L2Y08 | VPS4A PSMA6 CAPNS1 PSMB10 PSMD2 ITPR1 PTPRM MTOR DLAT UPP2 HTT | 1.34e-04 | 432 | 149 | 11 | CID000105082 |
| Drug | Gabrene | 1.34e-04 | 40 | 149 | 4 | CID005361323 | |
| Drug | BAPTA-AM | 1.39e-04 | 293 | 149 | 9 | CID000002293 | |
| Drug | riccardin D | 1.43e-04 | 76 | 149 | 5 | ctd:C547185 | |
| Drug | gaboxadol | 1.48e-04 | 41 | 149 | 4 | CID000003448 | |
| Drug | riluzole | 1.52e-04 | 174 | 149 | 7 | CID000005070 | |
| Drug | fluo-3 | 1.54e-04 | 122 | 149 | 6 | CID000104978 | |
| Drug | 5 beta-alphaxalone | 1.62e-04 | 42 | 149 | 4 | CID000068930 | |
| Drug | TMB-8 | 1.63e-04 | 176 | 149 | 7 | CID000005494 | |
| Drug | zolpidem | 1.75e-04 | 17 | 149 | 3 | ctd:C049109 | |
| Drug | AC1L88YH | 1.75e-04 | 17 | 149 | 3 | CID000374551 | |
| Disease | HIV Infections | 1.28e-05 | 103 | 146 | 6 | C0019693 | |
| Disease | HIV Coinfection | 1.28e-05 | 103 | 146 | 6 | C4505456 | |
| Disease | – | 6.34e-05 | 16 | 146 | 3 | 609423 | |
| Disease | Susceptibility to HIV infection | 6.34e-05 | 16 | 146 | 3 | cv:C1836230 | |
| Disease | non-Hodgkin lymphoma (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:0060060 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.02e-04 | 49 | 146 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | thrombin activatable fibrinolysis inhibitor activation peptide measurement | 1.08e-04 | 19 | 146 | 3 | EFO_0008582 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.45e-04 | 4 | 146 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Chagas disease (biomarker_via_orthology) | 3.60e-04 | 6 | 146 | 2 | DOID:12140 (biomarker_via_orthology) | |
| Disease | pyruvate decarboxylase deficiency (is_implicated_in) | 3.60e-04 | 6 | 146 | 2 | DOID:3649 (is_implicated_in) | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 3.60e-04 | 6 | 146 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | Schizophrenia | GABRB1 GABRB2 GABRB3 DGCR2 SP1 MCHR1 HLA-C GRIN2C ZDHHC8 SERPINI1 WDR11 MTOR KIF2A | 4.62e-04 | 883 | 146 | 13 | C0036341 |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 5.02e-04 | 7 | 146 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 6.41e-04 | 477 | 146 | 9 | C0005586 | |
| Disease | Abnormality of the skeletal system | 6.68e-04 | 8 | 146 | 2 | C4021790 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 6.68e-04 | 8 | 146 | 2 | DOID:1312 (is_marker_for) | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 6.68e-04 | 8 | 146 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | reticulocyte measurement | SP1 VWF ATR HLA-C KBTBD8 ARFGEF2 PSMD2 BIRC6 SLC9A5 FDFT1 LRP5 TLN2 EIF2AK4 PREX1 | 7.63e-04 | 1053 | 146 | 14 | EFO_0010700 |
| Disease | Colorectal Carcinoma | PMS2 ERCC2 NTHL1 ABCB5 APC2 OBSCN ABCA10 AKAP12 KCNH4 MCM3AP KDM2A | 7.69e-04 | 702 | 146 | 11 | C0009402 |
| Disease | anterior uveitis (biomarker_via_orthology) | 8.56e-04 | 9 | 146 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | colon cancer (biomarker_via_orthology) | 9.52e-04 | 39 | 146 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 9.52e-04 | 39 | 146 | 3 | DOID:526 (is_implicated_in) | |
| Disease | Abnormality of nervous system morphology | 1.07e-03 | 10 | 146 | 2 | C4022810 | |
| Disease | Neurodevelopmental Disorders | 1.19e-03 | 93 | 146 | 4 | C1535926 | |
| Disease | Shortened QT interval | 1.30e-03 | 11 | 146 | 2 | C0151879 | |
| Disease | nephritis (biomarker_via_orthology) | 1.30e-03 | 11 | 146 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | carbohydrate measurement | 1.54e-03 | 46 | 146 | 3 | EFO_0004998 | |
| Disease | renal fibrosis (biomarker_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 1.78e-03 | 447 | 146 | 8 | C3714756 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.83e-03 | 13 | 146 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.83e-03 | 13 | 146 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 1.83e-03 | 13 | 146 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.83e-03 | 13 | 146 | 2 | C4551952 | |
| Disease | Skin Abnormalities | 1.83e-03 | 13 | 146 | 2 | C0037268 | |
| Disease | Congenital Structural Myopathy | 1.83e-03 | 13 | 146 | 2 | C0752282 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.92e-03 | 260 | 146 | 6 | EFO_0008317 | |
| Disease | reticulocyte count | SP1 VWF ATR HLA-C BCAS3 KBTBD8 PSMD2 BIRC6 SLC9A5 FDFT1 LRP5 TLN2 EIF2AK4 | 2.12e-03 | 1045 | 146 | 13 | EFO_0007986 |
| Disease | Malformations of Cortical Development | 2.13e-03 | 14 | 146 | 2 | C1955869 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.13e-03 | 14 | 146 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.13e-03 | 14 | 146 | 2 | C0410207 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 2.13e-03 | 14 | 146 | 2 | C1150929 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.13e-03 | 14 | 146 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | beta-2-microglobulin measurement | 2.13e-03 | 14 | 146 | 2 | EFO_0020180 | |
| Disease | Cortical Dysplasia | 2.13e-03 | 14 | 146 | 2 | C0431380 | |
| Disease | fibrinogen measurement | 2.14e-03 | 109 | 146 | 4 | EFO_0004623 | |
| Disease | Alcoholic Intoxication, Chronic | 2.23e-03 | 268 | 146 | 6 | C0001973 | |
| Disease | granulocyte percentage of myeloid white cells | 2.23e-03 | 268 | 146 | 6 | EFO_0007997 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.45e-03 | 15 | 146 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.45e-03 | 15 | 146 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.45e-03 | 15 | 146 | 2 | C0154091 | |
| Disease | infant head circumference | 2.45e-03 | 15 | 146 | 2 | EFO_0004577 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 2.45e-03 | 15 | 146 | 2 | C3645536 | |
| Disease | Malignant neoplasm of breast | KIF6 VWF SLCO2B1 APC2 KBTBD8 OBSCN ARFGEF2 AKAP12 MTOR N4BP2 CST6 BOD1L1 ATP2A3 | 2.68e-03 | 1074 | 146 | 13 | C0006142 |
| Disease | Cardiovascular Abnormalities | 2.79e-03 | 16 | 146 | 2 | C0243050 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 2.79e-03 | 16 | 146 | 2 | EFO_0007633, HP_0012235 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | longevity | 2.97e-03 | 284 | 146 | 6 | EFO_0004300 | |
| Disease | Huntington Disease | 3.15e-03 | 17 | 146 | 2 | C0020179 | |
| Disease | Familial primary pulmonary hypertension | 3.15e-03 | 17 | 146 | 2 | C0340543 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.15e-03 | 17 | 146 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | mean arterial pressure | 3.50e-03 | 499 | 146 | 8 | EFO_0006340 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.53e-03 | 18 | 146 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Malignant neoplasm of endometrium | 3.53e-03 | 18 | 146 | 2 | C0007103 | |
| Disease | Carcinoma of bladder | 3.53e-03 | 18 | 146 | 2 | C0699885 | |
| Disease | Congenital Fiber Type Disproportion | 3.53e-03 | 18 | 146 | 2 | C0546264 | |
| Disease | Carcinoma in situ of endometrium | 3.53e-03 | 18 | 146 | 2 | C0346191 | |
| Disease | urate measurement, bone density | 3.78e-03 | 619 | 146 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.82e-03 | 128 | 146 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C0007134 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 4.15e-03 | 131 | 146 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 4.15e-03 | 131 | 146 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 4.15e-03 | 131 | 146 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 4.15e-03 | 131 | 146 | 4 | C3714758 | |
| Disease | calcium measurement | 4.16e-03 | 628 | 146 | 9 | EFO_0004838 | |
| Disease | renal system measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0004742 | |
| Disease | polymyositis | 4.36e-03 | 20 | 146 | 2 | EFO_0003063 | |
| Disease | red blood cell density measurement | SP1 ATR BCAS3 DNAH2 ARFGEF2 PSMD2 RBKS KDM2A KIF2A EIF2AK4 PREX1 | 4.46e-03 | 880 | 146 | 11 | EFO_0007978 |
| Disease | Juvenile-Onset Still Disease | 4.61e-03 | 135 | 146 | 4 | C0087031 | |
| Disease | haptoglobin measurement | 4.80e-03 | 21 | 146 | 2 | EFO_0004640 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 4.80e-03 | 21 | 146 | 2 | EFO_0004286, EFO_0004792 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DAMDICARDLSSGTM | 1086 | P53355 | |
| VFMLNDVLMCATVSS | 666 | O15013 | |
| KMAATQTGTCLMVAA | 366 | Q96BA8 | |
| SALGLCNSSAMAMII | 2996 | Q9NR09 | |
| SCDLLVVSVGQMSMS | 1396 | Q9P2K8 | |
| AMMVSGTLRCIGSIQ | 1411 | Q8WWZ4 | |
| MMAAAVADGTRAATI | 891 | Q02952 | |
| MVTGDSMLTAVSVAR | 746 | Q9H7F0 | |
| SMLTAVSVARDCGMI | 751 | Q9H7F0 | |
| LIMASAAACSRMVIS | 216 | Q2M3G0 | |
| GLDMARRCSVTSMES | 606 | Q9Y6D5 | |
| GLALCTLSTMGSAEM | 121 | O75843 | |
| TLSTMGSAEMCRDLA | 126 | O75843 | |
| AVACTLDMVMAGTET | 286 | Q8TAV3 | |
| DISNLRFCITGMMVI | 161 | O60706 | |
| VSGLRGTCLTVMMAT | 2626 | Q96M86 | |
| GTCLTVMMATRNVVR | 2631 | Q96M86 | |
| CMAFNTSGMLLVTTD | 356 | Q9H6U6 | |
| MVRVGTLIMCLHDVS | 236 | Q8N5B7 | |
| LSRVGSAMAMAALTT | 1076 | Q96F81 | |
| MSVCRMFVVAEADAG | 361 | Q93084 | |
| CTMEELRSLMELRGT | 26 | Q01814 | |
| AVRVIELCSSTMTCM | 486 | P24386 | |
| RLERCMSIVTSMTAG | 51 | Q68E01 | |
| LEGMVEATGMTCQAR | 276 | Q92806 | |
| IGLAVSRMAAVCIME | 436 | Q96PH1 | |
| RTSALLSGFAMVAMV | 66 | Q9BRQ5 | |
| EGMVEATGMTCQARS | 306 | P48544 | |
| QAARLGAMTSMVCKV | 61 | Q9H477 | |
| LMRADMGGAATICSA | 301 | P28838 | |
| MVEQISLCRAAMGRS | 536 | D6REC4 | |
| ALTAMESGVLLAMAC | 111 | Q6IF63 | |
| GCESTQATVEMTVSM | 111 | Q86XE5 | |
| SSMSRGEMSLAEVQC | 1791 | Q14643 | |
| MAGTVRTACLVVAML | 1 | P51654 | |
| TEGTLRICAVMGCIM | 2056 | Q2LD37 | |
| MMREQLQLSEATGTC | 1931 | O60318 | |
| IVRAFMDGTNCMTLV | 786 | O75197 | |
| RTSALLSGFAMVAMV | 91 | Q96D31 | |
| TVIADICRRMGIGMA | 141 | P37268 | |
| CLMVCDIRGTLMTVE | 176 | Q96MB7 | |
| LAVLGAVVTAMMCRR | 321 | P10321 | |
| AVVTAMMCRRKSSGG | 326 | P10321 | |
| CMLSGIDILISTSSM | 66 | Q8TCB6 | |
| MLGSTECVLLVVMSH | 106 | A6NFC9 | |
| MMSVTLSCDHRVVDG | 611 | P10515 | |
| GTREIGSALTRMCMR | 71 | O43312 | |
| IFRSMLMTACDLGAV | 806 | Q9HCR9 | |
| MRALAVLSVTLVMAC | 1 | P07202 | |
| TSRSQGEDCVMMRGS | 251 | P06734 | |
| VMGVTVSRLAMLSHC | 526 | Q9P265 | |
| VRVCFVTSMMTGRAA | 116 | Q86TG7 | |
| GGNCMTTMIATLSLE | 311 | Q6ZMV9 | |
| VEMRNCGVSVTEAML | 431 | Q14678 | |
| SICTMLIGALMHAVV | 456 | Q9UQ05 | |
| VTMATFTMTLARVCL | 476 | P18074 | |
| ATATIMLMGDTCTRG | 126 | O43766 | |
| YGLRITTTAACMMDL | 151 | P18505 | |
| GLRITTTAACMMDLR | 151 | P47870 | |
| YGLRITTTAACMMDL | 151 | P28472 | |
| TIRMTIDAGCSLHML | 186 | P78334 | |
| EMTGVCASQMALTLL | 306 | Q96F86 | |
| CVDEMLTLAAMLTAA | 486 | Q8TE96 | |
| ILSNSPVAAVMCSSM | 106 | Q6MZN7 | |
| CTQRLGMTASEMIIC | 276 | Q8NFY9 | |
| CEGTMAMLVIRGASL | 2876 | Q5VST9 | |
| SSVESGVLMAMALDC | 111 | Q8NGF1 | |
| TGVRFLRCPAAMTVM | 161 | P35227 | |
| NSRTCMIATISPGMA | 521 | O00139 | |
| AMISTSTSEGCEAVM | 2291 | Q8NFC6 | |
| LSVLCVMLSMAGSVL | 101 | P81408 | |
| VLQVMGSCAAISSMD | 11 | Q9ULW2 | |
| LAMSSSPESCVAMRR | 296 | O95996 | |
| MGTEGLFRRACEVTM | 2526 | Q13535 | |
| VASMVLGECRQMSSS | 391 | P51797 | |
| DESRKSCTVGMATMI | 1056 | P42858 | |
| SCTVGMATMILTLLS | 1061 | P42858 | |
| IQMCGVMLSGSEEST | 2856 | P42858 | |
| CVGSRRMVDVMDVNT | 101 | Q9Y2K7 | |
| AARCVGVMSKIATME | 1126 | O14981 | |
| MMGCFALQTVDTELT | 1 | Q9BTV6 | |
| CTVSAIMCVSMRGTI | 71 | Q8NCG7 | |
| IDTCRSMVAVMDSDT | 141 | P04632 | |
| ACREGRSAVVEMLIM | 41 | Q13418 | |
| MQVSTAALAVLLCTM | 1 | P10147 | |
| LLLCAGTQVSTAMEM | 861 | Q0VDD8 | |
| FDSMASGMRLVVSCI | 341 | P98153 | |
| GETMCTLITAMDANS | 181 | Q99705 | |
| MEMGSTDCRKTRVTG | 91 | Q15828 | |
| GMAFCSTLMTVSLLL | 341 | P11169 | |
| ALRTMSSLPESSAMC | 556 | Q9UKA1 | |
| ETMDSLAMVEGVSSC | 541 | Q86Y56 | |
| GFTLESCRSMIALMD | 691 | P20807 | |
| SCRSMIALMDTDGSG | 696 | P20807 | |
| LAMASPATVSRCGMV | 2211 | Q9P225 | |
| MGLMLATCSADGIVR | 126 | Q96EE3 | |
| TRGAAEMVLQMISAC | 3771 | P21817 | |
| MIGTVSMDDSCAALL | 571 | Q92845 | |
| RTGCFIVIDIMLDMA | 1101 | P28827 | |
| ICTATTEEACMVGRM | 66 | Q8WXA2 | |
| AAAVSGMIAISRMAV | 351 | Q99574 | |
| SSMESGVLVAMALDC | 126 | Q8NGH7 | |
| TTIMTRHLCAMLVGV | 131 | Q8NH37 | |
| TVFTCISMLARAMGP | 481 | P42345 | |
| VMMAASLALTGAVVA | 6 | Q86TM6 | |
| RNIEMESTVFAAMCG | 251 | O95045 | |
| EMARASCSALMSQPS | 856 | P46939 | |
| MRGVESQGMLLCASI | 431 | P54577 | |
| IECSAMAGTLLGASM | 346 | P49589 | |
| TSSVMPVDVAMRLCL | 16 | Q9UQK1 | |
| VLISAASVNLGSMMC | 36 | Q6NT16 | |
| ISVLAMTMSGERECL | 126 | Q13200 | |
| SMEVAGVTALACGMI | 511 | Q13200 | |
| ICMDSGGFRTTASMV | 276 | Q96FV2 | |
| MCSPQESGMTALSAR | 1 | P78549 | |
| VMCGTGMQRSTLSVS | 1581 | Q8TCU6 | |
| MASLSAILAVTMCGL | 296 | Q14940 | |
| MNDTLTSALMGACVT | 396 | Q5C9Z4 | |
| GVAADAEMTTRMVAS | 86 | P40306 | |
| SALITTNMVAMEAIC | 741 | P08047 | |
| NASTVAAAMCMVVTR | 391 | P10155 | |
| QLIREMLMCDTSGSI | 101 | Q9H0H5 | |
| RMVLALVCMSSEVGR | 341 | O75783 | |
| SLKGAVLTFSCMDRM | 891 | Q9Y2K9 | |
| DLQAARGLMCAASVM | 76 | P56748 | |
| MQVSTAALAVLLCTM | 1 | P16619 | |
| IGCVMTGMTADSRSQ | 76 | P60900 | |
| GITECDNMLMLLSVS | 166 | Q99611 | |
| GELTSMIMCDQCRTV | 361 | Q9Y5T5 | |
| CTCTDMEDAVMGLRV | 2451 | P04275 | |
| TMLDRVVMAGNCLEV | 391 | Q6ZVD8 | |
| GMLDCMVSSIRQEGL | 241 | Q8N413 | |
| VVLSQVCLSSMAAGM | 376 | O94956 | |
| KTVTDMLMTICARIG | 106 | Q9Y490 | |
| TAMIGCRLMSGILAV | 186 | Q9BY14 | |
| AMMDQGCREILTTAG | 381 | Q9NY15 | |
| IMVQQRMSLASCGTD | 1051 | Q92620 | |
| MFASRACRKSVMIGT | 806 | P54278 | |
| KASLCTDSRMEAGIM | 86 | Q6ZMY9 | |
| GLFSMIDCSMVQVRG | 71 | Q99595 | |
| VRTAVTMAVMCVAGL | 181 | Q9C0B5 | |
| VADLTGELMRMCINS | 191 | Q99598 | |
| NSRMLTILCEEMGSE | 1046 | O95789 | |
| DTIMCVTESIFSSMG | 806 | Q9Y4G6 | |
| VSTGAAAMMAVRVLL | 456 | Q9NWZ5 | |
| AHTTITMAVMCVAGL | 181 | Q9ULC8 | |
| MMCSSLEQALAVLVT | 1 | P29034 | |
| HTMSIMLAVDILGCT | 641 | Q8N5H7 | |
| MAAAVLMDRVQSCVT | 1 | Q9HCX3 | |
| LSSLFNTICMSGEML | 771 | Q5SVZ6 | |
| LASDDGCIRVLEMSM | 811 | Q9BZH6 | |
| SVSQMLRIVMEEGCS | 281 | Q9H9Y6 | |
| LLFGVMCTSMAVAAS | 386 | Q1EHB4 | |
| SESVAMISRSCMEIL | 546 | Q14679 | |
| GSAMRAAEQAGCMVS | 6 | Q2T9J0 | |
| LCIAHSRSSMEMEGI | 1716 | O75962 | |
| VVCMSDMLRSLATTR | 401 | Q9UN37 | |
| LGSSEMLLSEMTCES | 946 | Q86UW6 | |
| MLQAARDMVTTAGVS | 896 | Q14957 |